From data to evidence in medicines regulation
Update: In the context of the COVID-19 pandemic, this conference has been cancelled.
The European Medicines Agency (EMA) is holding this conference as part of a programme of events to celebrate its 25th anniversary.
Its objectives are to:
- explore the evolution to data-driven regulation;
- understand enablers, challenges and opportunities;
- discuss the opportunities to contribute to future actions.
Approximately 300 experts and stakeholders will be able to attend. Places will be allocated by a mixture of invitation and open call for interest.
EMA will publish an outline agenda and details on the registration process shortly.